Videos

Featured

Broadcast

Prevention & Chronic Conditions

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care

Vijay Chopra, Javed Butler, Dinesh Khullar , et al

Watch time: 1h 4m 2s

Nir Uriel

Watch time: 34m 39s (5 videos)
The Future of Heart Failure With Dr Yancy

Clyde W Yancy

Watch time: 9m 15s

Jasper J Brugts

Watch time: 2m 59s (15 videos)
AHA 25: HFpEF as an Adipose Tissue Disorder

Milton Packer

Watch time: 5m 43s
AHA 25 Late-breaking Discussion: Analysis from the SURPASS-CVOT Trial

Harriette Van Spall, Stephen Nicholls

Watch time: 12m 43s
AHA 25: The POLY-HF Trial

Ambarish Pandey

Watch time: 4m 15s
ESC 25 Hot Line Discussion: VICTOR: Vericiguat in Heart Failure

Harriette Van Spall, Faiez Zannad

Watch time: 13m 4s
ESC HF 25: The VELOCITY Study

Stephen J Greene

Watch time: 5m 30s
ESC 25: The REBOOT-CNIC Trial

Borja Ibanez

Watch time: 3m 53s
AHA 25: MAPLE-HCM Responder Analysis

Andrew Wang

Watch time: 3m
HFA 2023 Late-breaking Science Highlights With Dr Van Spall & Dr Januzzi

Harriette Van Spall, James L Januzzi

Watch time: 13m 32s
HFA 23: Dapagliflozin and PAD in HF

Jawad Haider Butt

Watch time: 3m 50s
HFA 23: IRONMAN: Reasons for Hospitalisation and Biomarkers

John GF Cleland

Watch time: 8m 44s
HFA 23: TRANSFORM-HF: Torsemide Vs Furosemide on Quality of Life in Heart Failure

Stephen J Greene

Watch time: 5m 11s
HFA 23: Diagnosis in Heart Failure in Women

John GF Cleland

Watch time: 8m 22s
HFA 23: IRONMAN: Anemia, Iron Deficiency and Quality of Life

Paul Kalra

Watch time: 5m 25s

Gianluigi Savarese, Mark Petrie, Stephen J Greene, et al

Watch time: 57m 5s (4 videos)

Broadcast

Intervention

MI/ACS
Transforming STEMI Care: Bridging Interventional and HF Cardiology

Sandeep Nathan, Dan Burkhoff, Jerry D Estep , et al

Watch time: 1h 31s
HFA 23: Trientine-HCL for Treatment of HFrEF

James L Januzzi, Harriette Van Spall

Watch time: 4m 3s
HFA 23: The DELIVER Phase III Trial

Martin R Cowie

Watch time: 8m 33s

Harriette Van Spall, Clyde W Yancy

Watch time: 1h 1m 16s (8 videos)

Watch time: 14m 21s
Potential Reversibility of ATTR-CM through Anti-ATTR Amyloid Antibodies

Marianna Fontana

Watch time: 8m 1s

Finn Gustafsson, Maja Cikes

Watch time: 7m 32s (2 videos)
Conversations about HCM: Symptoms, Diagnosis and Management

Ankur Kalra,

Watch time: 51m 52s

Broadcast

Guidelines & Statements

Heart Failure
Updates in HCM Management: ESC Cardiomyopathy Guidelines 2023

Elena Arbelo, Juan-Pablo Kaski,

Watch time: 59m 7s